docetaxel anhydrous has been researched along with Hematoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandre, J; Astorg, F; Boudou-Rouquette, P; Chabanol, H; Du Mortier, C; Goldwasser, F; Huillard, O; Musenghesi, B; Prin, L; Rondeau, A; Villeminey, C | 1 |
1 other study(ies) available for docetaxel anhydrous and Hematoma
| Article | Year |
|---|---|
[Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Feasibility Studies; Hematoma; Humans; Male; Middle Aged; Nail Diseases; Onycholysis; Photography; Podiatry; Prostatic Neoplasms; Retrospective Studies | 2018 |